Healthcare ❯ Pharmaceuticals

Biopharmaceuticals

Drug Development Clinical Trials Generic Drugs Therapeutics Oncology Treatments Duchenne Muscular Dystrophy Corporate Acquisitions Teva Pharmaceutical Industries Limited Insmed Respiratory Diseases Radiopharmaceuticals Animal Health Rare Diseases Vaccines Product Launches Oncology Generic Medicines Bristol-Myers Squibb Company Clinical-stage Biopharmaceutical Companies

Telix Investors Face Jan. 9 Deadline in Securities Class Action Tied to SEC, FDA Disclosures

Plaintiff firms are pressing affected shareholders to seek lead-plaintiff status before the court’s cutoff.

Telix Investors Face Jan. 9 Deadline in Securities Suit Over Drug and Manufacturing Disclosures

Telix Securities Suit Advances as Investor Firms Push Lead-Plaintiff Bids Before Jan. 9 Deadline

Bristol Myers and J&J Cast as Dividend Plays as Bayer’s FXIa Win Refocuses Pipeline Interest

Lilly Steps Up Obesity Push With San Diego Innovation Hub and $6.5 Billion Houston Factory

PGIM Jennison’s Q2 Letter Details Health-Care Slide, Portfolio Shifts and Company Catalysts

BMO Raises AbbVie Target to $240 After Rinvoq Generic Dispute Is Resolved

Teva Wins FDA Fast Track for Emrusolmin in Multiple System Atrophy

Biohaven Investors Face Sept. 12 Deadline in Securities Class Action